Close Menu
Home » Agilent, MRM Proteomics Extend Co-marketing Agreement

Agilent, MRM Proteomics Extend Co-marketing Agreement

Jul 24, 2014
|
staff reporter

NEW YORK (GenomeWeb) – Agilent Technologies today announced the extension of a co-marketing agreement with MRM Proteomics.

The extension expands a deal between the companies reached in September 2012, and will allow the partners to improve their combined proteomics solutions comprising reagents kits, hardware, and software, Agilent said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Back for Another Round

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

Imprints Left Behind

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

Get the Most Out of It

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

Cell Papers Explore Translation, Messenger RNA Localization

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.

What's Popular?

In Proteomics & Protein Research

  1. Inscripta Looks to Combine CRISPR, Single-Cell Genomics, Synthetic Biology in New Platform

    Premium

  2. IsoPlexis Wins $4M SBIR Grant From NCI

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.